-
Sales of semaglutide increased by 152%!
August 18,2020.
According to statistics, the number of diabetes patients in the world has reached 425 million in 2017.It is estimated that the number of diabetes patients in the world will reach 629 million in 2045.D...
View More
-
mPEG-MA | SINOPEG peg derivative functional group
April 9,2025.
1. Definition and chemical structure mPEG-MA, full name Methoxy Polyethylene Glycol Methacrylate, is a bifocal compound consisting of the following two parts: Methoxy-polyethylene glycol (mPEG) chain:...
View More
-
Stability ADC Linker
November 24,2025.
In the field of targeted delivery, ADC (antibody-drug conjugate) technology has become one of the key technologies driving the development of related fields due to its dual advantages of "precise reco...
View More
-
The Role of Polyethylene Glycol as a Pharmaceutical Excipient
December 29,2025.
Polyethylene glycol (PEG), as a pharmaceutical excipient, is widely used in drug formulation development and production due to its good biocompatibility, water solubility, and tunable physicochemical ...
View More
-
Introduction to tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu, CAS: 1118767-16-0
January 16,2026.
tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu is a specialized chemical side-chain intermediate crucial for the synthesis of the anti-diabetic drug Semaglutide. Basic Chemical Information Item Information CAS Numbe...
View More
-
Accelerate Radiopharmaceutical R&D with a Complete Precursor Building Block Platform
May 11,2026.
At Sinopeg, we’re dedicated to empowering radiopharmaceutical innovators with a comprehensive library of precursor building blocks covering all three core modules of radiopharmaceutical molecules: Lig...
View More
-
The Right Cold Precursor Can Make or Break Your Radiopharma Program
July 21,2026.
In radiopharmaceutical R&D, non-radioactive precursors are the critical starting point. Their quality, availability, and modular flexibility directly impact your timeline from hit to IND-and ultim...
View More
-
Novo Long-Acting Growth Hormone Side Chain
August 19,2026.
The Novo long-acting growth hormone side chain is a fatty acid-modified functional side chain designed for long-acting modification strategy research. This molecule combines a fatty acid structural un...
View More
-
HA-CHO | Hyaluronate Aldehyde | Sinopeg Functionalized Hyaluronic Acid Product
September 15,2026.
1. Introduction(Structure image) Hyaluronate Aldehyde (abbreviated as HA-CHO) is an aldehyde-functionalized derivative of hyaluronic acid (HA). By selectively oxidizing hydroxyl groups on the hyaluron...
View More